Skip to main content
Amy Shapiro, MD, Pediatric Hematology & Oncology, Indianapolis, IN

AmyDanaShapiroMD

Pediatric Hematology & Oncology Indianapolis, IN

Pediatric Coagulation Disorder Hematology

Medical Director CEO Indiana Hemophilia & Thrombosis Center

Dr. Shapiro is on Doximity

As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.

  • Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
  • Connect with colleagues in the same hospital or clinic.
  • Read the latest clinical news, personalized to your specialty.

See Dr. Shapiro's full profile

Already have an account?

  • Office

    8326 Naab Rd
    Indianapolis, IN 46260
    Phone+1 317-871-0000
    Fax+1 317-871-0010

Summary

  • Amy Shapiro, MD, based in Indianapolis, IN, is a specialist in Pediatric Hematology & Oncology with a subspeciality in Pediatric Coagulation Disorder Hematology. She completed her Fellowship and Residency at the University of Colorado and is a graduate of New York University School of Medicine. Dr. Shapiro has extensive experience treating conditions like hemophilia, anemia, and sickle cell anemia. She has several publications in respected journals including Haemophilia, The Lancet, European Journal of Haematology, and Research and Practice in Thrombosis and Haemostasis. Dr. Shapiro has also been the principal investigator in numerous clinical trials focused on treatments for hemophilia and Von Willebrand Disease.

Education & Training

  • University of Colorado
    University of ColoradoFellowship, Pediatric Hematology/Oncology, 1983 - 1987
  • University of Colorado
    University of ColoradoResidency, Pediatrics, 1980 - 1983
  • New York University School of Medicine
    New York University School of MedicineClass of 1980

Certifications & Licensure

  • IN State Medical License
    IN State Medical License 1987 - 2025
  • CO State Medical License
    CO State Medical License 1983 - 1987
  • Pediatrics
    American Board of Pediatrics Pediatrics
  • Pediatric Hematology-Oncology
    American Board of Pediatrics Pediatric Hematology-Oncology

Clinical Trials

Publications & Presentations

PubMed

Lectures

  • B-YOND Final Results Confirm Established Safety, Sustained Efficacy, and Extended Dosing Interval for Up to 4 Years of Treatment With rFIXFc in Previously Treated Subj... 
    2018 ASH Annual Meeting - San Diego, CA - 12/1/2018
  • On-Demand Treatment of Bleeding Episodes in Patients with Hereditary Factor X Deficiency Using a High-Purity Factor X Concentrate: Data from 2 Clinical Trials and a Da... 
    2018 ASH Annual Meeting - San Diego, CA - 12/1/2018

Press Mentions

  • FDA Approves Alhemo® Injection as Once-Daily Prophylactic Treatment to Prevent or Reduce the Frequency of Bleeding Episodes for Adults and Children 12 Years of Age and Older with Hemophilia a or B with Inhibitors
    FDA Approves Alhemo® Injection as Once-Daily Prophylactic Treatment to Prevent or Reduce the Frequency of Bleeding Episodes for Adults and Children 12 Years of Age and Older with Hemophilia a or B with InhibitorsDecember 21st, 2024
  • Novo Nordisk Bleeding Disorder Injection Gets USFDA Nod
    Novo Nordisk Bleeding Disorder Injection Gets USFDA NodDecember 20th, 2024
  • Gene Found in Indiana Amish Could Help Find Drug for Longevity
    Gene Found in Indiana Amish Could Help Find Drug for LongevityNovember 27th, 2017
  • Join now to see all